A Randomised, Open-label, Three-way Cross-over, Phase I Study in Healthy Subjects to Assess the Pharmacokinetics of AZD8329 After Single Doses of the Oral Solid Formulation and the Oral Solution.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2011
At a glance
- Drugs AZD 8329 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 01 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 01 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2010 Additional location (England) identified as reported by ClinicalTrials.gov.